L Louboutin1, A Viste2, R Desmarchelier3, M-H Fessy3. 1. Service de chirurgie orthopédique et traumatologique, hospices civils de Lyon, centre hospitalier Lyon-Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France. 2. Service de chirurgie orthopédique et traumatologique, hospices civils de Lyon, centre hospitalier Lyon-Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France; Université de Lyon, 69622 Lyon, France; Université Claude Bernard Lyon 1, 43, boulevard du 11 Novembre, 69100 Villeurbanne, France; IFSTTAR, UMRT_9406, laboratoire de biomécanique et mécanique des Chocs, 25, avenue Mitterrand, 69500 Bron, France. Electronic address: anthony.viste@chu-lyon.fr. 3. Service de chirurgie orthopédique et traumatologique, hospices civils de Lyon, centre hospitalier Lyon-Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France; Université de Lyon, 69622 Lyon, France; Université Claude Bernard Lyon 1, 43, boulevard du 11 Novembre, 69100 Villeurbanne, France; IFSTTAR, UMRT_9406, laboratoire de biomécanique et mécanique des Chocs, 25, avenue Mitterrand, 69500 Bron, France.
Abstract
INTRODUCTION: The Corail™ stem, which was first introduced in 1986, has since been modified twice: first to make the neck thinner and then to change the location of the laser markings. The survival and complications of the first-generation straight, titanium, hydroxyapatite-coated stem are known; however, there is little specific information about the latest-generation stem. This led us to conduct a retrospective study to determine the: (1) long-term survival; (2) clinical and radiographic outcomes; (3) complications; and (4) risk factors for revision of the newest Corail™ stem. HYPOTHESIS: The newest Corail™ AMT (Articul/EZE™ Mini Taper) standard stem has comparable survival to prior models. PATIENTS AND METHODS: This single-center, retrospective study included 133 patients (140 hips), who underwent primary total hip arthroplasty (THA), between January and December 2004, in which a Corail™ Standard stem was implanted using a posterolateral approach. Patients who underwent revision THA, THA due to femoral neck fracture or who received lateralized (offset) stems were excluded. The mean age at the time of THA was 69±13 years [35-92] in 85 men (61%) and 55 women (39%) who had a mean BMI of 27kg/m2±11 [16-39]. At the latest follow-up, 32 patients (32 hips) had died and 8 patients (8 hips) had less than 3 years' follow-up, thus were not included in the clinical evaluation. The Merle d'Aubigné (PMA) score was collected. The stem's survivorship was calculated using the Kaplan-Meier method with revision for aseptic loosening and revision or implant removal for any reason as the end-points. The Cox model was used to analyze risk factors for revision. The mean follow-up was 10±3 years [3-12]. RESULTS: The PMA score was 12±2.6 [5-17] preoperatively and 16±2.7 [7-18] at the last follow-up (P<0.00001). Eighteen complications (12.8%) were recorded at the last follow-up. There were 15 early complications: 6 dislocations, 5 calcar fractures (4 treated by wire cerclage and 1 by stem change plus wire cerclage), 2 greater trochanter fractures (treated non-surgically) and 2 cases of sciatic nerve palsy. There were 3 late complications: 2 cases of iliopsoas irritation and 1 ceramic insert fracture. Stem survival for surgical revision due to aseptic loosening was 98% (95% CI: [0.96-1]). At 12 years, 95% of stems had not been revised or removed (95% CI: [0.92-0.99]). Being less than 58 years of age at the time of surgery was the only risk factor significantly associated with stem revision for any reason (P=0.04). CONCLUSION: Survival of the Corail™ Standard stem is similar to that of previous generation stems. The changes made in this stem solved the neck failure problem and did not induce new complications. LEVEL OF EVIDENCE: Level IV (retrospective study).
INTRODUCTION: The Corail™ stem, which was first introduced in 1986, has since been modified twice: first to make the neck thinner and then to change the location of the laser markings. The survival and complications of the first-generation straight, titanium, hydroxyapatite-coated stem are known; however, there is little specific information about the latest-generation stem. This led us to conduct a retrospective study to determine the: (1) long-term survival; (2) clinical and radiographic outcomes; (3) complications; and (4) risk factors for revision of the newest Corail™ stem. HYPOTHESIS: The newest Corail™ AMT (Articul/EZE™ Mini Taper) standard stem has comparable survival to prior models. PATIENTS AND METHODS: This single-center, retrospective study included 133 patients (140 hips), who underwent primary total hip arthroplasty (THA), between January and December 2004, in which a Corail™ Standard stem was implanted using a posterolateral approach. Patients who underwent revision THA, THA due to femoral neck fracture or who received lateralized (offset) stems were excluded. The mean age at the time of THA was 69±13 years [35-92] in 85 men (61%) and 55 women (39%) who had a mean BMI of 27kg/m2±11 [16-39]. At the latest follow-up, 32 patients (32 hips) had died and 8 patients (8 hips) had less than 3 years' follow-up, thus were not included in the clinical evaluation. The Merle d'Aubigné (PMA) score was collected. The stem's survivorship was calculated using the Kaplan-Meier method with revision for aseptic loosening and revision or implant removal for any reason as the end-points. The Cox model was used to analyze risk factors for revision. The mean follow-up was 10±3 years [3-12]. RESULTS: The PMA score was 12±2.6 [5-17] preoperatively and 16±2.7 [7-18] at the last follow-up (P<0.00001). Eighteen complications (12.8%) were recorded at the last follow-up. There were 15 early complications: 6 dislocations, 5 calcar fractures (4 treated by wire cerclage and 1 by stem change plus wire cerclage), 2 greater trochanter fractures (treated non-surgically) and 2 cases of sciatic nerve palsy. There were 3 late complications: 2 cases of iliopsoas irritation and 1 ceramic insert fracture. Stem survival for surgical revision due to aseptic loosening was 98% (95% CI: [0.96-1]). At 12 years, 95% of stems had not been revised or removed (95% CI: [0.92-0.99]). Being less than 58 years of age at the time of surgery was the only risk factor significantly associated with stem revision for any reason (P=0.04). CONCLUSION: Survival of the Corail™ Standard stem is similar to that of previous generation stems. The changes made in this stem solved the neck failure problem and did not induce new complications. LEVEL OF EVIDENCE: Level IV (retrospective study).
Authors: Marcel Haversath; Martin Lichetzki; Sebastian Serong; André Busch; Stefan Landgraeber; Marcus Jäger; Tjark Tassemeier Journal: Arch Orthop Trauma Surg Date: 2020-05-30 Impact factor: 3.067
Authors: Nils Wirries; Marcus Örgel; Michael Schwarze; Stefan Budde; Henning Windhagen; Michael Skutek Journal: Arch Orthop Trauma Surg Date: 2021-08-14 Impact factor: 2.928
Authors: Silje Marie Melbye; Sofie Cecilia Dietrich Haug; Anne Marie Fenstad; Ove Furnes; Jan-Erik Gjertsen; Geir Hallan Journal: Clin Orthop Relat Res Date: 2021-10-01 Impact factor: 4.755
Authors: Ramakanth R Yakkanti; Dylan N Greif; Dennis J Vanden Berge; Raymond P Robinson Journal: Arch Orthop Trauma Surg Date: 2022-03-03 Impact factor: 3.067
Authors: Alain Cypres; Arnaud Fiquet; Philippe Girardin; David Fitch; Philippe Bauchu; Olivier Bonnard; Daniel Noyer; Christophe Roy Journal: J Orthop Surg Res Date: 2019-11-21 Impact factor: 2.359
Authors: L Pisecky; J Allerstorfer; B Schauer; G Hipmair; R Hochgatterer; N Böhler; T Gotterbarm; M C Klotz Journal: J Orthop Surg Res Date: 2020-11-26 Impact factor: 2.359